byiShook Opinion
Sep 20, 2024 - 11:30
European regulators rejected Apellis Pharmaceuticals' embattled eye drug, Syfovre, and Apellis stock tumbled to a month-low. The post Apellis Stock Hammered After Eye Drug Gets A Third European Rejection appeared first on Investor's Business Daily.
European regulators rejected Apellis Pharmaceuticals' embattled eye drug, Syfovre, and Apellis stock tumbled to a month-low.
The post Apellis Stock Hammered After Eye Drug Gets A Third European Rejection appeared first on Investor's Business Daily.